Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Diseases

Explore clinical trials studying Gastrointestinal Diseases. Study availability and eligibility vary by location and protocol.

18,009 public trials 3,508 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Diseases trial results

Recruiting

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

NCT07058012

Conditions
Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa - Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Missouri Baptist St Louis, Missouri, United States
View all 13 locations
View Trial Details
Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

NCT05673148

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 187 locations
View Trial Details
Recruiting

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

NCT06445972

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 8905) Los Angeles, California, United States
  • Norton Cancer Institute - Downtown ( Site 8900) Louisville, Kentucky, United States
  • The Cancer and Hematology Centers ( Site 8912) Grand Rapids, Michigan, United States
View all 46 locations
View Trial Details
Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

NCT06252649

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Ironwood Cancer and Research Centers Scottsdale Chandler, Arizona, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
  • City of Hope National Medical Center Long Beach, California, United States
  • Cancer and Blood Research Center, LLC Los Alamitos, California, United States
View all 291 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details

Related conditions